Guo, M., Guan, Y., Hu, S., Zhang, Q., Lin, J., Xu, Z., . . . Zhong, Y. (2026). CT‑based radiomics of bowel wall at baseline predicts the efficacy of Ustekinumab at week 16 in patients with Crohn's disease. Abdominal Radiology, 51(6), 2764. https://doi.org/10.1007/s00261-025-05247-6
Chicago Style (17th ed.) CitationGuo, Minyi, et al. "CT‑based Radiomics of Bowel Wall at Baseline Predicts the Efficacy of Ustekinumab at Week 16 in Patients with Crohn's Disease." Abdominal Radiology 51, no. 6 (2026): 2764. https://doi.org/10.1007/s00261-025-05247-6.
MLA (9th ed.) CitationGuo, Minyi, et al. "CT‑based Radiomics of Bowel Wall at Baseline Predicts the Efficacy of Ustekinumab at Week 16 in Patients with Crohn's Disease." Abdominal Radiology, vol. 51, no. 6, 2026, p. 2764, https://doi.org/10.1007/s00261-025-05247-6.